Homing peptides are exploited in nanomedicine to functionalize either free drugs or nanostructured materials used as drug carriers. However, the influence of multivalent versus monovalent peptide presentation on the interaction with the receptor and on the consequent intracellular delivery of the associated cargo remains poorly explored. By using a tumor-homing peptide (T22) with regulatable selfassembling properties we have investigated here if its display in a either a monomeric form or as multimeric, self-assembled protein nanoparticles might determine the efficacy of receptor-mediated penetrability into target cells. This has been monitored by using a fluorescent cargo protein (iRFP), which when fused to the homing peptide acts as convenient reporter. The results indicate that the nanoparticulate protein versions are significantly more efficient in mediating receptor-dependent uptake than their unassembled counterparts. These finding stresses an additional benefit of nanostructured materials based on repetitive building blocks, regarding the multivalent presentation of cell ligands that facilitate cell penetration in drug delivery applications.
Introduction
Cell targeted drug delivery is expected to result in high concentration levels of drugs in desired cells and tissues, aiming to minimize side effects of chemotherapies and to thereby improve the patient's quality of life.
Tumor-homing peptides specifically internalize cancer cells via specific binding to over-expressed cellsurface receptors. Therefore, they have been explored for use as targeting tools in drug delivery, either fused to therapeutic proteins [5] , coupled to drugs or therapeutic nucleic acids [2, 17] , or as functionalizing agents of different types of nanoparticles intended as drug carriers [1, 8] . Under the combined development of materials sciences and nanomedicine it is however unclear whether tumor-homing peptides are more effective in promoting passenger drug penetration when formulated as plain molecular preparations or as multimeric presentations on nanoparticulate entities.
Recently, we have developed a new protein engineering principle to construct protein-only nanoparticles for targeted drug and DNA delivery in cancer [12, 14, 15] . This has been possible through the construction of selfassembling building blocks containing tumor homing peptides, which organized as highly stable nanoscale entities. The size of these constructs (> 8 nm) allow them to escape renal filtration [4] , thus exhibiting a convenient biodistribution upon administration and exclusively accumulating in primary tumor and metastatic foci [13] . Among the set of different building blocks generated under this principle, the protein T22-IRFP-H6 exhibits unique assembling properties. In a standard physiological buffer, it organizes as toroidal nanoparticles but in presence of high salt content, the building blocks remain fully disassembled. The possibility to regulate the assembling of T22-IRFP-H6 offers an exceptional opportunity to comparatively explore, in the same molecular species, whether the cell targeting and internalization properties of T22, a potent ligand of CXCR4 [13] , are influenced by its presentation as either free protein molecules or as regular assembled, protein-only nanoparticles.
Materials and methods

Protein production and characterization
T22-IRFP-H6 was produced by standard procedures [4] . After purification, the protein was collected and dialyzed against two alternative buffers: NaHCO 3 166 mM, pH=7.8 and NaHCO 3 166 mM, NaCl 333 mM, pH=7.8, overnight at 4 ºC. Fluorescence emission spectrum was measured at 710 nm, by using a JASCO FP-8000 spectrofluorometer (JASCO, US), with an excitation wavelength of 635 nm. volume size distribution of nanoparticles and monomeric proteins were determined by dynamic light scattering (DLS, Zetasizer Nano ZS, Malvern Instruments Limited, Malvern, UK), at 633 nm. For size exclusion chromatography (SEC) was done in a calibrated Superdex200 10/300GL (Tricorn) column (GE Healthcare).
Cell culture, flow cytometry and competition assay
HeLa cells (ATCC-CCL-2) were grown on 24 wells plate for 24 h in OptiPRO™ SFM medium (Life technologies) supplemented with 3 mM L-Glutamine. Recombinant proteins were added to each well at a final concentration of 2 µM and further incubated 24 h. After that, the medium was removed and cells washed with PBS and incubated with 1 mg/ml trypsin for 15 min to remove protein bound to cell surface.
Cells were centrifuged at 4,000 g for 5 min to remove trypsin, and collected and resuspended in PBS. Cells were analyzed on a FACSCanto system (Becton Dickinson), using a 15 W air-cooled argon-ion laser at 635 nm excitation. IRFP fluorescence was measured with detector A (780/60 nm band pass filter). For the competition assay, AMD3100 was added 1 h before proteins. Protein internalization was determined 24 h later by flow cytometry.
Confocal microscopy
HeLa cells were cultured on Mat-Teck culture dishes (Mat Teck Corp., Ashland, MA, USA) with serum-free medium for 24 h. Proteins were added with a final concentration of 2 μM. After 24 h, cells were washed with PBS and nuclei and membranes stained with Hoechst 33342 and concanavalin A respectively for 10 min.
After washing with PBS complete medium was added and stained cells were examined using a TCS-SP5 confocal laser scanning microscope (Leica Microsystems, Heidelberg, Germany) with a Plan Apo 63×/1.4 (oil HC × PL APO l blue) objective M.
Cryo transmission electron microscopy (CryoTEM)
Microdrops of purified proteins (3 μL) were deposited on Quantifoil R1.2/1.3 grids, put in liquid ethane in a Leica EM CPC and immediately placed in a Gatan cryo-transfer specimen holder. Samples were observed in a Jeol JEM 2011 transmission electron microscope, operating at 200 kV and equipped with a CCD Gatan 895 USC 4000 camera.
Field emission scanning electron microscopy (FESEM)
Microdrops (5 µl) of protein sample were added to a silicon wafer and air-dried at room temperature. Native structure of samples was observed in a FESEM Zeiss Merlin operating at 2kV equipped with a highresolution in-lens secondary electron detector.
Results and discussion
Features of protein materials
Upon production in bacteria, T22-IRFP-H6 occurred as an individual molecular species of 38.6 kDa that partially adopted a dimeric form (77.2 kDa) (Fig 1A) , the natural organization of iRFP [6] . Further dialysis in front a physiological buffer or a buffer containing 500 mM salt, did not alter the integrity of the protein ( Fig   1B) . However, in low salt buffer, T22-IRFP-H6 organized as supramolecular entities formed by around 10 monomers (Fig 1C) , that were seen as regular nanoparticles of 15 nm by DLS (Fig 1D) . Particle formation was fully confirmed by FESEM (Fig 1E) and by cryo-TEM (Fig 1F) . No nanoparticles were observed when T22-IRFP-H6 was dialyzed against high salt buffer (Fig 1C-E) .
Comparative analysis of cellular internalization
Upon approving the robustness of the analytical system we approached the comparative testing of the CXCR4-mediated cell penetrability of free T22-IRFP-H6 protein and T22-IRFP-H6 nanoparticles. We aimed to determine if the nanostructured display of the CXCR4 ligand T22 might significantly influence receptor binding and subsequent cell uptake or contrarily, if such a formulation is irrelevant regarding the performance of the tumor-homing peptide. iRFP constructs, being fully fluorescent [4] , are convenient reporters in internalization assays, as free and nanostructured versions of T22-IRFP-H6 showed indistinguishable specific emission values of 13.4 ± 0.14 and 12.8 ± 0.23 U/mg respectively. At the same molar ratio, both forms of T22-IRFP-H6 were internalized into CXCR4 + HeLa cells, while the control, IRFP-H6 remained extracellular (Fig 2A) . However, T22-IRFP-H6 nanoparticles were internalized much more efficiently than T22-IRFP-H6 free protein, and under the same conditions, the amount of protein uptake as nanoparticles doubled that of penetrating target cells as disassembled entities.
Interestingly, the CXCR4 antagonist AMD3100, a very specific and highly potent inhibitor of CXCR4 binding [3, 7] , blocks the entry of T22-IRFP-H6 nanoparticles more efficiently than that of soluble protein (Figure 2A ).
The milder blocking of disassembled protein uptake might be indicative that, not only the cell penetrability of T22 is enhanced by a nanoparticulate formulation but also the specificity of binding to the cell surface receptor. However, very low background binding of free T22-IRFP-H6 to CXCR4 -SW1417 cells was also observed (Fig 2B) , thereby discarding the possibility of a significant interaction of this species to an alternative receptor.
The confocal analysis of CXCR4 + HeLa cells exposed to both protein versions confirmed the enhanced cell penetrability of the nanoparticulate T22-IRFP-H6 isoform (Fig 2C) . This protein version was visualized as discrete intracellular entities found in endosomal vesicles, free in the cytoplasm and perinuclear area ( Fig   2D) , and in agreement with the endosome-mediated penetration previously described for T22-empowered polypeptides [4] . Altogether, these results confirm that despite both assembled and disassembled versions of T22-IRFP-H6 internalize target cells via the tumor marker CXCR4, the penetrability of the nanostructured version is clearly higher than that of the free version. This fact is probably related to the multiple presentation of T22 on regular nanoparticles, and to the consequent multivalent receptor binding that enhances endosome formation and penetration [11] , as it occurs in natural viruses [9] .
Conclusions
In summary, we described here an enhanced performance of the tumour-homing peptide T22 as multimeric versus monomeric forms, regarding receptor-mediated cell internalization. This finding stresses the convenience to formulate targeting peptides, used for Trojan horse approaches of molecular medicine, in multivalent material arrangements. Therefore, drug delivery through carrier nanoparticles would profit not only from a higher penetrability, longer circulation time and improved stability compared to free drug versions [16] , but they will also offer a convenient platform for the multiple and regular display of homing peptides.
Therefore, the "artificial virus" concept in nanomedicine [10] 
